About the Journal
Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.
Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.
With a large international editorial board of experts who are leaders in their fields, Annals of Oncology aims at delivering the best communication on the fast moving, and continually evolving, global oncology landscape.
Annals Of Oncology is covered by the following major indexing services:
Current Contents® /Clinical Medicine
Elsevier BIOBASE - Current Awareness in Biological Sciences (CABS)
Journal Citation Reports /Science Edition
Prous Science Integrity®
Science Citation Index Expanded (SciSearch®)
Science Citation Index®
IMPACT FACTOR AND RANKING
|Year||Impact Factor||Si: Oncology|
|2015||9.269||11 out of 213|
|2014||7.040||18 out of 211|
|2013||6.578||18 out of 202|
|2012||7.384||18 out of 196|
|2011||6.425||17 out of 194|
|2010||6.452||20 out of 184|
|2009||5.647||19 out of 165|
|2008||4.935||26 out of 141|
|2007||4.875||23 out of 132|
|2006||5.179||21 out of 127|
This information is taken from the Journal Citation Reports, published annually as part of the Science Citation Index by ISI.